Literature DB >> 23125242

Extramedullary involvement in multiple myeloma.

Joan Bladé, Carlos Fernández de Larrea, Laura Rosiñol.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23125242      PMCID： PMC3487431          DOI： 10.3324/haematol.2012.078519

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  20 in total

1.  Myeloma as a model for the process of metastasis: implications for therapy.

Authors:  Irene M Ghobrial
Journal:  Blood       Date:  2012-04-24       Impact factor: 22.113

Review 2.  Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach.

Authors:  Joan Bladé; Carlos Fernández de Larrea; Laura Rosiñol; María Teresa Cibeira; Raquel Jiménez; Ray Powles
Journal:  J Clin Oncol       Date:  2011-09-06       Impact factor: 44.544

3.  Extensive soft-tissue involvement by plasmablastic myeloma arising from displaced humeral fractures.

Authors:  Carlos Fernández De Larrea; Laura Rosiñol; María Teresa Cibeira; María Rozman; Montserrat Rovira; Joan Bladé
Journal:  Eur J Haematol       Date:  2010-11       Impact factor: 2.997

Review 4.  Mouse models of human myeloma.

Authors:  Constantine S Mitsiades; Kenneth C Anderson; Daniel R Carrasco
Journal:  Hematol Oncol Clin North Am       Date:  2007-12       Impact factor: 3.722

5.  Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.

Authors:  Ola Landgren; Robert A Kyle; Ruth M Pfeiffer; Jerry A Katzmann; Neil E Caporaso; Richard B Hayes; Angela Dispenzieri; Shaji Kumar; Raynell J Clark; Dalsu Baris; Robert Hoover; S Vincent Rajkumar
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

6.  A monoclonal gammopathy precedes multiple myeloma in most patients.

Authors:  Brendan M Weiss; Jude Abadie; Pramvir Verma; Robin S Howard; W Michael Kuehl
Journal:  Blood       Date:  2009-02-20       Impact factor: 22.113

7.  Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients.

Authors:  M Varettoni; A Corso; G Pica; S Mangiacavalli; C Pascutto; M Lazzarino
Journal:  Ann Oncol       Date:  2009-07-24       Impact factor: 32.976

Review 8.  International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.

Authors:  M Dimopoulos; E Terpos; R L Comenzo; P Tosi; M Beksac; O Sezer; D Siegel; H Lokhorst; S Kumar; S V Rajkumar; R Niesvizky; L A Moulopoulos; B G M Durie
Journal:  Leukemia       Date:  2009-05-07       Impact factor: 11.528

9.  Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.

Authors:  Chen-Feng Qi; Jeff X Zhou; Chang Hoon Lee; Zohreh Naghashfar; Shao Xiang; Alexander L Kovalchuk; Torgny N Fredrickson; Janet W Hartley; Derry C Roopenian; Wendy F Davidson; Siegfried Janz; Herbert C Morse
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

10.  The impact of extramedullary disease at presentation on the outcome of myeloma.

Authors:  Ping Wu; Faith E Davies; Kevin Boyd; Karen Thomas; Sharon Dines; Radovan M Saso; Mike N Potter; Mark E Ethell; Bronwen E Shaw; Gareth J Morgan
Journal:  Leuk Lymphoma       Date:  2009-02
View more
  20 in total

1.  Relapsing Multiple Myeloma Presenting as Cardiac Tamponade and Obstructive Uropathy.

Authors:  Bright E Izekor; Pruthali Kulkarni; Priscilla R Powell; James Hall; Rex C Garland
Journal:  Cureus       Date:  2021-04-15

2.  Relapsing Extramedullary Multiple Myeloma Presenting As Acute Liver Failure.

Authors:  Hafiza Wajeeha Javaid; Farrukh Munir; Saman Bahram
Journal:  Cureus       Date:  2021-12-28

Review 3.  Risk factors in multiple myeloma: is it time for a revision?

Authors:  Jill Corre; Nikhil C Munshi; Hervé Avet-Loiseau
Journal:  Blood       Date:  2021-01-07       Impact factor: 25.476

4.  Nonsecretory multiple myeloma presenting as an intestinal tumor.

Authors:  Diana Triantafyllopoulou; Stuart Mellor; Catherine Cargo; Ioannis Gkikas; Jagdish Adiyodi; Ayub Ali Bin; Neil Sahasrabudhe; Margaret Rokicka
Journal:  Case Rep Hematol       Date:  2015-04-16

5.  Extramedullary manifestation in multiple myeloma bears high incidence of poor cytogenetic aberration and novel agents resistance.

Authors:  Xiaoyan Qu; Lijuan Chen; Hairong Qiu; Hua Lu; Hanxin Wu; Hongxia Qiu; Peng Liu; Rui Guo; Jianyong Li
Journal:  Biomed Res Int       Date:  2015-04-23       Impact factor: 3.411

6.  Extramedullary Soft Tissue Involvement and Discrepant Osseous Uptake on Tc-99m MDP and Ga-67 Citrate Scintigraphy in a Patient With Multiple Myeloma: A Case Report and Literature Review.

Authors:  Szu-Ying Tsai; Shan-Ying Wang; Yu-Chien Shiau; Yen-Wen Wu
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

7.  PET/CT F18-FDG with soft tissue plasmacytomas in multiple myeloma.

Authors:  Alejandro Martí; Sarai Morón; Sandra Chinchilla; Eliana González
Journal:  Eur J Hybrid Imaging       Date:  2021-03-31

8.  Obstructive Jaundice as Initial Presentation of Multiple Myeloma: Case Presentation and Literature Review.

Authors:  Yasir Khan; Iyad Mansour; Eric Ong; Manish Shrestha
Journal:  Case Rep Med       Date:  2015-06-21

9.  Efficacy of lenalidomide in association with cyclophosphamide and dexamethasone in multiple myeloma patient with bilateral retro-orbital localisation.

Authors:  S Felici; N Villivà; G Balsamo; A Andriani
Journal:  Ecancermedicalscience       Date:  2013-07-10

10.  Incidental Discovery of Multiorgan Extramedullary Plasmacytomas in the Setting of Newly Diagnosed Multiple Myeloma and Delayed Hemolytic Transfusion Reaction.

Authors:  Joselle Cook; Steven Song; Anthony Ventimiglia; Carol Luhrs
Journal:  Case Rep Hematol       Date:  2017-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.